Islet Transplantation for Type 1 Diabetes

NCT00014911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus, Insulin-Dependent

Interventions

PROCEDURE: Islet Transplantation
DRUG: Sirolimus
DRUG: Tacrolimus
DRUG: Daclizumab
DRUG: Sulfamethoxazole
DRUG: Ganciclovir
DRUG: Trimethoprim
DRUG: Pentamidine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]